Advice
Following an abbreviated submission
Aripiprazole tablets 5mg (Abilify) are accepted for restricted use in NHS Scotland for the treatment of schizophrenia. Where aripiprazole is an appropriate antipsychotic, this new dosage is restricted to patients who may benefit from a dose reduction to 5mg daily, taking account of SMC advice issued in August 2004. This 5mg tablet is the same price as the 10mg and 15mg tablets
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Aripiprazole (Abilify®)
- SMC ID:
- 187/05
- Indication:
- Schizophrenia
- Pharmaceutical company
- Bristol-Myers Squibb Pharmaceuticals Ltd
- BNF chapter
- Central nervous system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 11 July 2005